TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 DKK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
34,161
|
24,596
|
28,935 |
| Financial expenses |
127
|
45
|
104 |
| Earnings before taxes |
728
|
559
|
1,319 |
| EBITDA |
682
|
381
|
1,424 |
| Total assets |
59,504
|
46,068
|
37,058 |
| Current assets |
59,504
|
46,068
|
37,058 |
| Current liabilities |
31,615
|
20,055
|
12,072 |
| Equity capital |
27,889
|
26,013
|
24,986 |
| - share capital |
173
|
164
|
164 |
| Employees (average) |
11
|
16
|
16 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
46.9%
|
56.5%
|
67.4% |
| Turnover per employee |
3,106
|
1,537
|
1,808 |
| Profit as a percentage of turnover |
2.1%
|
2.3%
|
4.6% |
| Return on assets (ROA) |
1.4%
|
1.3%
|
3.8% |
| Current ratio |
188.2%
|
229.7%
|
307.0% |
| Return on equity (ROE) |
2.6%
|
2.1%
|
5.3% |
| Change turnover |
8,021
|
-3,749
|
1,751 |
| Change turnover % |
31%
|
-13%
|
6% |
| Chg. No. of employees |
-5
|
0
|
-2 |
| Chg. No. of employees % |
-31%
|
0%
|
-11% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.